Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Kündig

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Allergy|June 15, 2011
Immunotherapy concepts under investigationT M Kündig
Praxis|October 19, 2000
[Methods for increasing the immunogenicity of vaccines]T M Kündig
Therapeutische Umschau. Revue Therapeutique|June 16, 2001
[Therapy of chronic urticaria and recurrent Quincke edema]T M Kündig
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent ILD Binder, T M Kündig
Current Opinion in Immunology|April 1, 1994
In vivo versus in vitro assays for assessment of T- and B- cell functionM F Bachmann, T M Kündig
Allergy|August 26, 2016
Allergen-specific immunotherapy: is it vaccination against toxins after all?M F Bachmann, T M Kündig
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2018
Letter to the Editor: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part IIB Wüthrich, G Senti, T M Kündig
Praxis|October 21, 2010
[Allergen specific immunotherapy: new approaches]F Tay, T M Kündig, G Senti
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1993
T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organsT M Kündig, H Hengartner, R M Zinkernagel
Therapeutische Umschau. Revue Therapeutique|November 10, 2005
[HIV-1 vaccination--is there hope?]R F Speck, C Brander, T M Kündig
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Allergy|June 15, 2011
Immunotherapy concepts under investigationT M Kündig
Praxis|October 19, 2000
[Methods for increasing the immunogenicity of vaccines]T M Kündig
Therapeutische Umschau. Revue Therapeutique|June 16, 2001
[Therapy of chronic urticaria and recurrent Quincke edema]T M Kündig
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent ILD Binder, T M Kündig
Current Opinion in Immunology|April 1, 1994
In vivo versus in vitro assays for assessment of T- and B- cell functionM F Bachmann, T M Kündig
Allergy|August 26, 2016
Allergen-specific immunotherapy: is it vaccination against toxins after all?M F Bachmann, T M Kündig
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2018
Letter to the Editor: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part IIB Wüthrich, G Senti, T M Kündig
Praxis|October 21, 2010
[Allergen specific immunotherapy: new approaches]F Tay, T M Kündig, G Senti
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1993
T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organsT M Kündig, H Hengartner, R M Zinkernagel
Therapeutische Umschau. Revue Therapeutique|November 10, 2005
[HIV-1 vaccination--is there hope?]R F Speck, C Brander, T M Kündig
Pageof 7